Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Cy3 Goat Anti-Mouse IgG (H+L) Antibody: Mechanism, Eviden...

    2025-12-05

    Cy3 Goat Anti-Mouse IgG (H+L) Antibody: Mechanism, Evidence & Signal Amplification in Immunofluorescence

    Executive Summary: The Cy3 Goat Anti-Mouse IgG (H+L) Antibody is a polyclonal secondary antibody from APExBIO designed for sensitive detection of mouse immunoglobulins in fluorescence-based assays (product page). This antibody is affinity-purified and conjugated to Cy3 dye, enabling robust signal amplification in immunofluorescence, flow cytometry, and immunohistochemistry (Peng et al., 2024). Its mechanism amplifies primary antibody signals by facilitating multiple secondary bindings per target. The antibody is validated for high reproducibility and minimal cross-reactivity under standard assay conditions. Proper handling (storage at 4°C or -20°C; protection from light) maximizes its functional stability for up to 12 months.

    Biological Rationale

    Secondary antibodies labeled with fluorescent dyes are essential for detecting and quantifying primary antibody-bound targets in immunoassays. The Cy3 Goat Anti-Mouse IgG (H+L) Antibody specifically recognizes both heavy and light chains of mouse IgG, making it broadly compatible with mouse-derived primary antibodies. Signal amplification is achieved as each primary antibody can bind multiple Cy3-conjugated secondary antibodies, increasing fluorescence intensity and assay sensitivity. This approach is fundamental in proteomics, where sensitive detection of protein biomarkers (e.g., HMGB1 in diabetic nephropathy) is required (Peng et al., 2024). Such enhanced detection enables early disease monitoring and accurate quantitation of biomarker expression changes, as demonstrated in recent serum proteomics studies.

    Mechanism of Action of Cy3 Goat Anti-Mouse IgG (H+L) Antibody

    This antibody is generated by immunizing goats with pooled mouse immunoglobulins, followed by immunoaffinity purification. The product is then conjugated to Cy3, a fluorescent dye with excitation/emission maxima of ~550/570 nm. Upon application, the antibody binds specifically to mouse IgG primary antibodies attached to target antigens. The Cy3 fluorophore converts excitation light into a strong emission signal, which can be detected via fluorescence microscopy or flow cytometry. Multiple Cy3-labeled secondaries binding to each primary enhances overall signal, increasing assay sensitivity and dynamic range (Mechanism article). This mechanism is particularly effective for low-abundance target proteins or early-stage biomarker detection.

    Evidence & Benchmarks

    • Affinity-purified polyclonal antibodies demonstrate high specificity for mouse IgG (H+L) with negligible cross-reactivity when validated against human and rat IgG (Peng et al., 2024, DOI).
    • Cy3 conjugation provides stable fluorescence with excitation at 550 nm and emission at 570 nm, suitable for standard filter sets (K1207 product, APExBIO).
    • Signal amplification enables detection of targets at femtomole levels in immunofluorescence assays (see Table 2, Peng et al., 2024).
    • Validated for use in immunofluorescence, flow cytometry, and immunohistochemistry across multiple sample types and fixation conditions (Signal Amplification article).
    • Long-term storage at -20°C with 23% glycerol buffer maintains antibody functionality for at least 12 months without freeze/thaw cycles (APExBIO).

    Applications, Limits & Misconceptions

    The Cy3 Goat Anti-Mouse IgG (H+L) Antibody is suitable for:

    • Immunofluorescence microscopy in cell and tissue samples.
    • Flow cytometry for quantifying mouse IgG-bound targets.
    • Immunohistochemistry for spatial mapping of protein biomarkers.
    • Proteomics workflows for validating candidate biomarkers (e.g., HMGB1 in diabetic nephropathy).

    This reagent is not intended for clinical diagnostics or therapeutic use. It should not be used with non-mouse primary antibodies, as specificity is not guaranteed. Overexposure to light or repeated freeze/thaw cycles will degrade Cy3 fluorescence, reducing assay performance.

    Common Pitfalls or Misconceptions

    • Using the antibody with non-mouse primary antibodies may result in poor binding or non-specific signals.
    • Exposure to ambient light during storage or use can cause rapid photobleaching of the Cy3 dye.
    • Repeated freeze/thaw cycles will reduce antibody and fluorescence activity.
    • Excessive secondary antibody concentration may increase background fluorescence.
    • Not all filter sets are optimized for Cy3 detection; ensure proper instrument configuration.

    Workflow Integration & Parameters

    To maximize performance, dilute the Cy3 Goat Anti-Mouse IgG (H+L) Antibody in PBS with 1% BSA to minimize background. Incubate with the sample for 30–60 minutes at room temperature in the dark. Wash thoroughly before imaging or flow cytometry analysis. Store short-term at 4°C (up to 2 weeks) or aliquot and freeze at -20°C for up to 12 months. Avoid more than one freeze/thaw cycle per aliquot. Use filter sets compatible with Cy3 (excitation: 550 nm; emission: 570 nm). For advanced protocols and troubleshooting, see the product page and mechanism overview.

    This article extends the in-depth mechanistic discussion in "Cy3 Goat Anti-Mouse IgG (H+L) Antibody: Mechanism, Validation & Proteomics Integration" by providing new benchmarking data and updated application protocols. For a focus on advanced signal amplification in translational research, see "Signal Amplification"; this article contextualizes those findings within biomarker discovery workflows. For next-generation biomarker sensitivity in quantitative proteomics, this recent review compares Cy3-labeled secondaries to other fluorophore conjugates.

    Conclusion & Outlook

    The Cy3 Goat Anti-Mouse IgG (H+L) Antibody (K1207) from APExBIO is a validated, robust tool for sensitive detection of mouse IgG in fluorescence-based research. Its high specificity, strong signal amplification, and compatibility with proteomics workflows make it ideal for quantitative biomarker studies, including early detection of disease states such as diabetic nephropathy. Careful handling and workflow integration ensure consistent, reproducible results. As proteomic technologies advance, Cy3-conjugated secondary antibodies will remain vital for high-resolution, quantitative immunoassays (Peng et al., 2024).